Cargando…
Helicobacter pylori: present status and future prospects in Japan
The discovery of Helicobacter pylori has already changed the natural history of peptic ulcer disease, with most patients being cured at their first presentation. Similarly, the incidence of gastric cancer and other diseases related to H. pylori are likely to be greatly reduced in the near future. Is...
Autores principales: | Suzuki, Hidekazu, Hibi, Toshifumi, Marshall, Barry James |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780612/ https://www.ncbi.nlm.nih.gov/pubmed/17322988 http://dx.doi.org/10.1007/s00535-006-1990-z |
Ejemplares similares
-
Quinolone-Based Third-Line Therapy for Helicobacter pylori
Eradication
por: Nishizawa, Toshihiro, et al.
Publicado: (2009) -
What Is the Difference Between Helicobacter pylori-Associated Dyspepsia and Functional Dyspepsia?
por: Suzuki, Hidekazu, et al.
Publicado: (2011) -
Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis
por: Suzuki, Hidekazu, et al.
Publicado: (2009) -
Therapy of Helicobacter pylori: Present Medley and Future Prospective
por: Talebi Bezmin Abadi, Amin
Publicado: (2014) -
Proton pump inhibitor-amoxicillin-clarithromycin versus proton pump inhibitor-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapy
por: Nishizawa, Toshihiro, et al.
Publicado: (2012)